【序号】：1 【作者】：Haghighat S 【题名】：Recombinant PBP2a as avaccine candidate against methicillin-resistant Staphylococcus aureus:Immunogenicity and protectivity. 【期刊】：Microb Pathog. 【年、卷、期、起止页码】：2017 Jul;108:32-39. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/28457901 【序号】：2 【作者】：Haghighat S 【题名】：Cloning, expression andpurification of autolysin from methicillin-resistant Staphylococcus aureus:potency and challenge study in Balb/c mice. 【期刊】：Mol Immunol. 【年、卷、期、起止页码】：2017 Feb;82:10-18. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/28006655 【序号】：3 【作者】：Begier E 【题名】：SA4Ag, a 4-antigenStaphylococcus aureus vaccine, rapidly induces high levels of bacteria-killingantibodies. 【期刊】：Vaccine. 【年、卷、期、起止页码】：2017 Feb 22;35(8):1132-1139. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/28143674 【序号】：4 【作者】：Creech CB 【题名】： Safety,tolerability, and immunogenicity of a single dose 4-antigen or 3-antigenStaphylococcus aureus vaccine in healthy older adults: Results of a randomisedtrial. 【期刊】：Vaccine. 【年、卷、期、起止页码】： 2017 Jan 5;35(2):385-394. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/27866765 【序号】：5 【作者】：Frenck RW Jr 【题名】： Safety,tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine(SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2study. 【期刊】：Vaccine. 【年、卷、期、起止页码】： 2017 Jan 5;35(2):375-384. 【全文链接】：https://www.ncbi.nlm.nih.gov/pubmed/27916408
应助达人
赛默飞实验室产品焕新计划有奖调研！
【七月征文】不一YOUNG实验“猿”
报名开启：ICS2024第十三届光谱网络会议！
推荐收藏！盘点中药材及饮片检测解决方案
